HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies. While trastuzumab deruxtecan has shown superior activity ...
Study to be conducted by PharmaLegacy, a leading Contract Research Organization The scientific rationale for evaluating ...
The so-called guards are tumor macrophages. Under normal conditions, macrophages serve as first responders, helping fight infections and repair tissue damage. Inside tumors, however, these cells are ...
Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 2:30 PM ESTCompany ParticipantsRafael Amado - President and Head ...
Northwestern Medicine scientists have discovered a potent immunotherapy approach for treating meningiomas, the most common ...
GA, UNITED STATES, February 3, 2026 / EINPresswire.com / — Atomically engineered nanozymes ( AENs) combine precise nanotechnology with catalytic functions to enhance immune regulation through ...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today presented data on its novel ...
Immunotherapy has transformed the treatment landscape for many cancers, yet its efficacy remains highly variable across tumor types and patient populations.
Researchers reveal that eosinophils suppress chordoma growth, highlighting its potential as an immunotherapeutic target ...
Researchers uncover a redox-regulated mechanism that determines whether bone fractures heal or progress to nonunion ...
St. Jude Children’s Research Hospital scientists and multinational collaborators created AI-powered M-PACT to facilitate next-generation classification of pediatric brain tumors by liquid biopsy.
Frontiers in Oncology publication positions metabo-oncology as a differentiated platform for pharma and a novel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results